SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-060079
Filing Date
2021-10-08
Accepted
2021-10-08 17:22:23
Documents
2
Period of Report
2021-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4056
2 POA DOCUMENT poa.txt EX-24.4_1012385 4674
  Complete submission text file 0001209191-21-060079.txt   10183
Mailing Address 499 ILLINOIS STREET, SUITE 200 SAN FRANCISCO CA 94158
Business Address
Ehrlich Christopher B (Reporting) CIK: 0001293973 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 211316124

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations